July 9, 2025 - 04:54

KULR Technology's stock experienced significant gains after the company announced it had secured a $20 million loan from Coinbase Credit. This news initially sent the stock soaring, as investors reacted positively to the potential for increased capital and growth opportunities. However, the stock has since retraced much of its early momentum, raising questions about the sustainability of the surge.
The company's strategic shift toward a Bitcoin-focused business model has generated interest among investors, suggesting potential for future growth. This pivot aligns with the increasing integration of cryptocurrency in various sectors, indicating that KULR may be positioning itself to capitalize on the expanding digital currency market.
Despite the initial excitement, the long-term outlook for KULR remains uncertain. Investors are closely monitoring how effectively the company can leverage its new financial resources and adapt to the evolving landscape of cryptocurrency. As KULR navigates this transition, market participants will be keen to see if the stock can regain its upward trajectory.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...